FDA Clears Two New Alzheimer’s Blood Tests from Roche, C2N Diagnostics
The Food and Drug Administration has cleared two new blood tests for Alzheimer’s disease, expanding options for diagnosing cognitive decline early. Roche’s Elecsys pTau217 test is authorized for adults aged ... Read More